Device Trial Radar · NCT06784466
Coherent Sine Burst Electroporation (CSE) Ablation System US IDE Study for Patients With Atrial Fibrillation
Last checked: Nov 20, 2026Latest source record: Jul 15, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
360
Planned (sponsor's estimate)
Start
Sep 10, 2025
Primary completion
Jun 2027
Study completion Aug 2027
Sponsor
- Lead sponsor
- Arga Medtech SANot on our public-company list
- Sponsor type
- Industry
- First posted
- Jan 20, 2025
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Non randomized
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years, up to 80 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
To evaluate the safety and effectiveness of the Argá Medtech CSE Ablation System in the treatment of atrial fibrillation.
Conditions
- Atrial Fibrillation (AF)
- Persistant Atrial Fibrillation
- Paroxysmal AF
Interventions
Argá Medtech Coherent Sine-Burst Electroporation (CSE) Ablation SystemDevice
Ablation using the Argá Medtech Coherent Sine-Burst Electroporation (CSE) Ablation System
Primary outcomes
What the sponsor says the trial is designed to measure.
- Safety: Number of Participants With at Least One Primary Safety Event.Time frame: Up to 180 days
- Effectiveness: Number of Participants With Treatment Success.Time frame: Up to 12 months
Locations
27 sites in 6 countries. Site status is shown where the registry gives one.
Grandview
Birmingham, Alabama · Recruiting
Banner University Med Ctr
Phoenix, Arizona · Recruiting
Arrhythmia Research Group
Jonesboro, Arkansas · Recruiting
24 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.